NJ A 5534
in committeeRevises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
New Jersey · 222
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did NJ A 5534 pass?
Not yet. NJ A 5534 is in committee and has not come to a final vote. Latest recorded action (2026-09-24): Introduced, Referred to Assembly Health Committee
What is NJ A 5534 about?
NJ A 5534 is a bill in the 222 titled “Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.”.
Who sponsors NJ A 5534?
Verrelli, Anthony S. is the primary sponsor of NJ A 5534.
- Introduced
- —
- Latest action
- 2026-09-24 — Introduced, Referred to Assembly Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Verrelli, Anthony S.primary
Committees
Not provided by source.
Action timeline
Newest first
2026-09-24
Introduced, Referred to Assembly Health Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-09-26T20:07:42.492342Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 5534. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.